Povidon-iodine applied for the treatment of chylothorax in children



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. The aim of this study is to demonstrate the experience of non-surgical treatment of congenital and acquired chylothorax in children using povidone-iodine.

Material and methods. The study presents results of treatment of 10 patients with chylothorax who had chemical pleurodesis with povidone-iodine. The study covered a time period from 2016 to 2020. The congenital character of the disease was registered in 2 patients, the acquired one - in 8 patients. The main indication for surgery was ineffective conservative therapy, including the withdrawal of feeding and the administration of preparation Octreotide. The procedure consisted of intrapleural injection of 4% povidone-iodine solution into the pleural cavity with the calculated dose of 1 ml/kg and solution exposure for 4 hours. Results. The interpleural administration of povidone-iodine was effective in all patients. Complications of chemical pleurodesis were observed in 2 patients and were associated with pulmonary edema on the injection side. Lymph outflow was stopped on average in 4 days. There was one adverse episode which developed because of the lung malformation incompatible with life. Conclusions. Intrapleural administration of povidone-iodine is an effective treatment of chylothorax in children.

About the authors

Yu. A. Kozlov

Irkutsk Regional Children’s Clinical Hospital;
Irkutsk State Medical Academy of Continuous Education;
Irkutsk State Medical University

Author for correspondence.
Email: yuriherz@hotmail.com
ORCID iD: 0000-0003-2313-897X

Yury A. Kozlov, Chief Doctor of the Irkutsk Regional Children’s Clinical Hospital; professor at department of pediatric surgery at the Irkutsk State Medical University; professor at department of pediatric surgery at the Irkutsk State Medical Academy of Continuing Education

664009, Irkutsk,

664003, Irkutsk,

664049, Irkutsk

Россия

K. A. Kovalkov

Kemerovo Clinical Pediatric Hospital

Email: fake@neicon.ru
ORCID iD: 0000-0001-6126-4198

650056, Kemerovo

Россия

S. S. Poloyan

Center for Maternity and Childhood Protection

Email: fake@neicon.ru
ORCID iD: 0000-0001-7042-6646

660074, Krasnoyarsk

Россия

P. Zh. Baradieva

Irkutsk Regional Children’s Clinical Hospital

Email: fake@neicon.ru
ORCID iD: 0000-0002-5463-6763

664000, Irkutsk

Россия

D. A. Zvonkov

Irkutsk State Medical University

Email: fake@neicon.ru
ORCID iD: 0000-0002-7167-2520

664003, Irkutsk

Россия

C. B. Ochirov

Irkutsk Regional Children’s Clinical Hospital

Email: fake@neicon.ru
ORCID iD: 0000-0002-6045-1087

664000, Irkutsk

Россия

V. S. Cheremnov

Irkutsk Regional Children’s Clinical Hospital

Email: fake@neicon.ru
ORCID iD: 0000-0001-6135-4054

664000, Irkutsk

Россия

V. M. Kapuller

Assuta University Medical Center, Ben-Gurion University

Email: fake@neicon.ru
ORCID iD: 0000-0003-0076-5778

Ashdod

Израиль

References

  1. Scottoni F., Fusaro F., Conforti A., Morini F., Bagolan P. Pleurodesis with povidone-iodine for refractory chylothorax in newborns: Personal experience and literature review. J Pediatr Surg. 2015 Oct; 50(10): 1722-5.
  2. Christofe N.M., Pessotti C.F.X., Paiva L., Jatene I.B. Incidence and Treatment of Chylothorax in Children Undergoing Corrective Surgery for Congenital Heart Diseases. Braz J Cardiovasc Surg. 2017 Sep-Oct; 32(5): 390-3.
  3. Dorsi M., Giuseppi A., Lesage F., Stirnemann J., De Saint Blanquat L., Nicloux M., Assaf Z., Khen Dunlop N., Kermorvant-Duchemin E., Magny J.F., Ville Y., Lapillonne A. Prenatal factors associated with neonatal survival of infants with congenital chylothorax. J Perinatol. 2018 Jan; 38(1): 31-4.
  4. Concheiro-Guisan A., Alonso-Clemente S., Suarez-Albo M., DuranFernandez Feijoo C., Fiel-Ozores A., Fernandez-Lorenzo J.R. The Practicality of Feeding Defatted Human Milk in the Treatment of Congenital Chylothorax. 2019 Nov; 14(9): 648-53.
  5. White M.K., Bhat R., Greenough A. Neonatal Chylothoraces: A 10-Year Experience in a Tertiary Neonatal Referral Centre. Case Rep Pediatr. 2019; 2019: 3903598.
  6. Long W.G., Cai B., Deng J.M., Liu Y., Wang W.J., Luo J. Chemical pleurodesis and somatostatin in treating spontaneous chylothorax in pediatric patients: a retrospective analysis and review of the literature. Transl Pediatr. 2020 Aug; 9(4): 551-60.
  7. Le Nué R., Molinaro F., Gomes-Ferreira C., Scheib-Brolly C., Escande B., Kühn P., Lacreuse I., Favre R., Becmeur F. Surgical management of congenital chylothorax in children. Eur J Pediatr Surg. 2010 Sep; 20(5): 307-11.
  8. Moreira-Pinto J., Rocha P., Osório A., Bonet B., Carvalho F., Duarte C., Oliveira L. Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review. Pediatr Surg Int. 2011 Aug; 27(8): 805-9.
  9. Soto-Martinez M., Massie J. Chylothorax: diagnosis and management in children. Paediatr Respir Rev. 2009 Dec; 10(4): 199-207.
  10. Azizkhan R.G., Canfield J., Alford B.A., Rodgers B.M. Pleuroperitoneal shunts in the management of neonatal chylothorax. J Pediatr Surg. 1983 Dec; 18(6): 842-50.
  11. Brissaud O., Desfrere L., Mohsen R., Fayon M., Demarquez J.L. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003 Nov; 88(6): F531-3.
  12. De Beer H., Mol M., Janssen J. Chylothorax. Neth. J. Med. 2000; 56: 25–31.
  13. Kim J.E., Lee C., Park K.I., Park M.S., Namgung R., Park I.K. Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion. Korean J. Pediatr. 2012; 55: 177–80.
  14. Cho H., Na K., Kim D., Choi Y., Ma J., Jeong I. Chemical pleurodesis using a Viscum album extract in infants with congenital chylothorax. Eur. J. Pediatr. 2014; 173: 823–6.
  15. Mitanchez D., Walter-Nicolet E., Salomon R., Bavoux F., Hubert P. Congenital chylothorax: what is the best strategy? Arch. Dis. Child. Fetal Neonatal Ed. 2006; 91: F153–4.
  16. Roehr C.C., Jung A., Proquitté H., Blankenstein O., Hammer H., Lakhoo K., Wauer R.R. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med. 2006 May; 32(5): 650-7.
  17. Büttiker V., Fanconi S., Burger R.Chylothorax in children: guidelines for diagnosis and management. Chest. 1999 Sep; 116(3): 682-7.
  18. Rimensberger P.C., Müller-Schenker B., Kalangos A., Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg. 1998; 66: 253-4.
  19. Das A., Shah P.S. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010; 08: CD006388.
  20. Bellini C., Cabano R., De Angelis L.C., et al. Octreotide for congenital and acquired chylothorax in newborns: A systematic review. J Paediatr Child Health. 2018; 54: 840-7.
  21. Azam M.N., Majhi S.K., Mishra B.N., et al. Bilateral spontaneous chylothorax in a newborn and response to octreotide therapy. Int J Contemp Pediatr. 2017; 4: 658-60.
  22. Church J.T., Antunez A.G., Dean A., et al. Evidence-based management of chylothorax in infants. J Pediatr Surg. 2017; 52: 907-12.
  23. ÇakırU, KahvecioğluD, YıldızD, etal. Report of a case of neonatal chylothorax that responded to long-term octreotide treatment, and review of the literature. Turk J Pediatr.2015;57:195-7.
  24. Saito M., Kamoda T., Kajikawa D., et al. High Dose Octreotide for the Treatment of Chylothorax in Three Neonates. J Neonatal Biol. 2016; 5: 218.
  25. Dehghan K. Idiopathic Chylothorax in a Term Neonate and Successful Treatment with Octreotide and Medium Chain Triglyceride – Enriched Formula: A Case Report. Int J Pediatr. 2019; 7: 9535-40.
  26. Cleveland K., Zook D., Harvey K., Woods R.K. Massive chylothorax in small babies. J Pediatr Surg. 2009 Mar; 44(3): 546-50.
  27. Beghetti M., La Scala G., Belli D., Bugmann P., Kalangos A., Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr. 2000 May; 136(5): 653-8.
  28. Wolff A.B., Silen M.L., Kokoska E.R., Rodgers B.M. Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. Ann Thorac Surg. 1999 Sep; 68(3): 1053-7.
  29. Mattei P., Ed. Fundamentals of Pediatric Surgery. New York: Springer; 2011, 311.
  30. Разумовский А.Ю., Степанов Э.А. Хилоторакс в детском возрасте. М.: ГЭОТАР-Медиа; 2011. Текст: электронный. URL: https://www.studmedlib.ru/book/970406793V0014.html
  31. Nath D.S., Savla J., Khemani R.G., Nussbaum D.P., Greene C.L., Wells W.J. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg. 2009; 88(1): 246-51.
  32. Pego-Fernandes P.M., Nascimbem M.B., Ranzani O.T., Shimoda M.S., Monteiro R., Jatene F.B. Video-assisted thoracoscopy as an option in the surgical treatment of chylothorax after cardiac surgery in children. J Bras Pneumol. 2011 Feb; 37(1): 28-35.
  33. Echavarría A., Pinzón V., Barés J.P., Fernández E. Intracavitary treatment of malignant pleural effusion with iodine-povidone. Rev Med Panama. 1991 Jan; 16(1): 69-74.
  34. Guo Y., Tang K., Bilaceroglu S., Kalomenidis I., Salleng K.J., Lane K.B., Light R.W. Iodopovidon is as effective as doxycycline in producing pleurodesis in rabbits. Respirology. 2010 Jan; 15(1): 119-1.
  35. Cohan R.H., Saeed M., Schwab S.J., Perlmutt L.M., Dunnick N.R. Povidone-iodine sclerosis of pelvic lymphoceles: a prospective study. UrolRadiol. 1988; 10(4): 203-6.
  36. Olivares-Torres C.A., Laniado-Laborín R., Chávez-García C., León-Gastelum C., Reyes-Escamilla A., Light R.W. Iodopovidone pleurodesis for recurrent pleural effusions. Chest. 2002; 122(2): 581-3.
  37. Agarwal R., Khan A., Aggarwal A.N., Gupta D. Efficacy & safety of iodopovidone pleurodesis: a systematic review & meta-analysis. Indian J Med Res. 2012 Mar; 135: 297-304.
  38. Murki S., Faheemuddin M., Gaddam P. Congenital chylothorax–successful management with chemical pleurodesis. Indian J Pediatr. 2010 Mar; 77(3): 332-4.
  39. Resch B., Freidl T., Reiterer F. Povidone-iodine pleurodesis for congenital chylothorax of the newborn. Arch Dis Child Fetal Neonatal Ed. 2016; 101: F87-8.
  40. Borcyk K., Kamil A., Hagerty K., Deer M., Tomich P., Anderson Berry A.L. Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report. Clin Case Rep. 2018 Feb 27; 6(4): 702-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies